2ⁿᵈ Edition of the Cancer R&D World Conference 2026

Scientific Sessions

Pediatric Oncology

Pediatric oncology focuses on diagnosing and treating cancers in children and adolescents, addressing unique biological and developmental considerations. Common types include leukaemia, brain tumours, and neuroblastoma, which often differ from adult cancers in behaviour and treatment response. At the Cancer Research and Development Conference 2025, this session will delve into advances in precision medicine, immunotherapies, and supportive care that improve young patients' survival rates and quality of life. Pediatric oncology emphasizes holistic care, including long-term monitoring for potential late treatment effects, ensuring a comprehensive approach to care.

Related Sessions

Current Landscape and Future Directions of Oncology Research
Oncogenic Signaling Pathways and Therapeutic Targets
Emerging Biomarkers for Cancer Detection and Prognosis
Cancer Prevention and Early Detection Strategies
Immuno Oncology and Cell Based Therapies
Innovations in Immuno Oncology
Cytokine Modulation and Immune Adjuvants in Cancer Immunotherapy
Cancer Vaccines
CAR T Cell Therapy: Clinical Progress and Challenges
Next Generation Cell and Gene Therapies in Oncology
Liquid Biopsy and Circulating Tumor DNA (ctDNA) Diagnostics
Companion Diagnostics
Artificial Intelligence and Machine Learning in Precision Oncology
Next Generation Targeted Therapies: KRAS, HER2, BRAF, and NRAS
Overcoming Drug Resistance: Mechanisms and Solutions
Oncology Pipeline
Trends in Antibody Drug Conjugates (ADCs)
Launch of Novel mAb Products for Cancer Therapy